Positive correlation between interleukin-1 receptor antagonist gene 86bp VNTR polymorphism and colorectal cancer susceptibility: a case-control study
- 116 Downloads
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Genetic variations in cytokine genes and their receptors lead to the severity of the disease. The interleukin-1 receptor antagonist (IL1RN) is a cytokine that inhibits interleukin-1 (IL-1) activity by binding to IL-1 receptors. Also, interleukin-4 (IL-4) is an anti-inflammatory cytokine that can play an important role in several cancers. The present case-control study was aimed to evaluate the association of IL-4 and IL1RN VNTR polymorphisms with the susceptibility to CRC in a sample of Iranian population provided by the Research Center for Gastroenterology and Liver Disease at Taleghani Hospital, Tehran. A total of 123 patients diagnosed with CRC and 152 healthy controls were recruited in the present study. Genomic DNA was extracted by salting out method from whole blood and genotyping of IL1RN and IL-4 VNTR polymorphisms were determined by PCR-based technology. Our study manifested the frequency of 1/2 and 2/4 genotypes of IL1RN 68bp VNTR polymorphism are significantly different between both groups (p = 0.0001 and p = 0.01 respectively). However, we could not find any correlation between IL-4 VNTR polymorphism and CRC cancer. It seems that 1/2 and 2/4 genotypes of IL1RN are correlated with CRC susceptibility in our population, although, more studies are needed to confirm our results.
KeywordsColorectal cancer Cytokines VNTR polymorphism IL-4 IL1RN
The authors thank Shahid Beheshti University of Medical Sciences Deputy of Research Affairs for funding this project (p/25/14/605).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Rafiemanesh H, Pakzad R, Abedi M, Kor Y, Moludi J, Towhidi F, et al. Colorectal cancer in Iran: epidemiology and morphology trends. EXCLI J. 2016;15:738.Google Scholar
- 4.Shadmani FK, Ayubi E, Khazaei S, Sani M, Hanis SM, Khazaei S et al. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiol Health 2017;39.Google Scholar
- 6.Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR et al. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Prev Biomarkers. 2014:cebp 0064.2014.Google Scholar
- 7.Mager LF, Wasmer M-H, Rau TT, Krebs P. Cytokine-induced modulation of colorectal cancer. Front Oncol. 2016;6.Google Scholar
- 12.Olver S, Apte S, Baz A, Kienzle N. The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth? HLA. 2007;69(4):293–8.Google Scholar
- 13.Salimi S, Mohammadoo-Khorasani M, Yaghmaei M, Mokhtari M, Moossavi M. Possible association of IL-4 VNTR polymorphism with susceptibility to preeclampsia. Biomed Res Int. 2014;2014:1–5.Google Scholar
- 14.Viet HT, Wågsäter D, Hugander A, Dimberg J. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer. Oncol Rep. 2005;14(4):915–8.Google Scholar
- 21.Jahantigh D, Salimi S, Mousavi M, Moossavi M, Mohammadoo-Khorasani M, Narooei-nejad M, et al. Association between functional polymorphisms of DNA double-strand breaks in repair genes XRCC5, XRCC6 and XRCC7 with the risk of systemic lupus erythematosus in South East Iran. DNA Cell Biol. 2015;34(5):360–6.CrossRefGoogle Scholar
- 26.Hughes LA, Simons CC, van den Brandt PA, van Engeland M, Weijenberg MP. Lifestyle, diet, and colorectal cancer risk according to (epi) genetic instability: current evidence and future directions of molecular pathological epidemiology. Curr Colorectal Cancer Rep. 2017;13(6):455–69.CrossRefGoogle Scholar
- 28.Gopal M. Role of cytokines in tumor immunity and immune tolerance to cancer. Cancer immunology. Springer; 2015. p. 93–119.Google Scholar
- 31.Ahmed AB, Zidi S, Ghazouani E, Mezlini A, Lagha A, Bouraoui S et al. Interleukin-1 receptor antagonist VNTR polymorphism and ovarian cancer susceptibility in Tunisian women. 2014.Google Scholar